Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has issued an update.
Recce Pharmaceuticals Ltd announced a proposed issue of securities, including warrants and ordinary shares, set to be issued by the end of 2025. This strategic move aims to bolster the company’s financial resources, potentially enhancing its market position and operational capabilities in the pharmaceutical sector.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of novel antibiotics. The company is involved in producing anti-infective drugs aimed at addressing the growing issue of antibiotic resistance.
Average Trading Volume: 214,547
Technical Sentiment Signal: Sell
Current Market Cap: A$90.84M
See more data about RCE stock on TipRanks’ Stock Analysis page.